{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T10:15:50Z","timestamp":1769422550600,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.dld.2019.05.005","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T20:45:51Z","timestamp":1559594751000},"page":"1604-1609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association of Autoimmune Hepatitis and Cardiovascular Disease"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6496-340X","authenticated-orcid":false,"given":"Alana","family":"Persaud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Kakked","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg","family":"Shulik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil","family":"Ahlawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.dld.2019.05.005_bib0005","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1080\/00365520802130183","article-title":"Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study","volume":"43","author":"Werner","year":"2008","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.dld.2019.05.005_bib0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"10.1016\/j.dld.2019.05.005_bib0015","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/gut.42.5.599","article-title":"The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis","volume":"42","author":"McFarlane","year":"1998","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.dld.2019.05.005_bib0020","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1111\/j.1572-0241.2002.05921.x","article-title":"Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis","volume":"97","author":"Czaja","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"9902","key":"10.1016\/j.dld.2019.05.005_bib0025","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0140-6736(12)62163-1","article-title":"Autoimmune hepatitis","volume":"382","author":"Heneghan","year":"2013","journal-title":"Lancet (London, Eng)"},{"issue":"1","key":"10.1016\/j.dld.2019.05.005_bib0030","first-page":"54","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"New Engl J Med Surg Collat Branches Sci"},{"issue":"1","key":"10.1016\/j.dld.2019.05.005_bib0035","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000282067","article-title":"Mouse models for experimental autoimmune hepatitis: limits and chances","volume":"28","author":"Hardtke-Wolenski","year":"2010","journal-title":"Dig Dis (Basel, Switz)"},{"issue":"6","key":"10.1016\/j.dld.2019.05.005_bib0040","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"American Association for the Study of Liver Diseases. (2010). Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1","key":"10.1016\/j.dld.2019.05.005_bib0045","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000347211","article-title":"Autoimmune hepatitis","volume":"31","author":"Strassburg","year":"2013","journal-title":"Dig Dis (Basel, Switz)"},{"issue":"1","key":"10.1016\/j.dld.2019.05.005_bib0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/liv.13458","article-title":"Autoimmune hepatitis: From current knowledge and clinical practice to future research agenda","volume":"38","author":"Sebode","year":"2018","journal-title":"Liver Int: Off J Int Assoc Study Liver"},{"issue":"2","key":"10.1016\/j.dld.2019.05.005_bib0055","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11684-015-0386-y","article-title":"Autoimmune hepatitis","volume":"9","author":"Sahebjam","year":"2015","journal-title":"Front Med"},{"issue":"4","key":"10.1016\/j.dld.2019.05.005_bib0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000444471","article-title":"The pathogenesis of autoimmune liver disease","volume":"34","author":"Arndtz","year":"2016","journal-title":"Dig Dis (Basel, Switz)"},{"issue":"1","key":"10.1016\/j.dld.2019.05.005_bib0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.14218\/JCTH.2014.00032","article-title":"Update on autoimmune hepatitis","volume":"3","author":"Liberal","year":"2015","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2019.05.005_bib0070","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12016-011-8294-7","article-title":"Molecular mimicry as a mechanism of autoimmune disease","volume":"42","author":"Cusick","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.dld.2019.05.005_bib0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaut.2012.11.001","article-title":"Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis","volume":"42","author":"Ehser","year":"2013","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.dld.2019.05.005_bib0080","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3748\/wjg.v21.i1.60","article-title":"Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics","volume":"21","author":"Gatselis","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.dld.2019.05.005_bib0085","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1007\/s10620-015-3708-7","article-title":"Transitioning from idiopathic to explainable autoimmune hepatitis","volume":"60","author":"Czaja","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"25","key":"10.1016\/j.dld.2019.05.005_bib0090","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1161\/01.CIR.102.25.3137","article-title":"Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention","volume":"102","author":"Cooper","year":"2000","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.dld.2019.05.005_bib0095","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1067\/mhj.2001.114974","article-title":"INTER-HEART: a global study of risk factors for acute myocardial infarction","volume":"141","author":"Ounpuu","year":"2001","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.dld.2019.05.005_bib0100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jacc.2008.08.074","article-title":"Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease","volume":"53","author":"Kitta","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.dld.2019.05.005_bib0105","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/hrt.60.6.459","article-title":"Morphology of the endothelium over atherosclerotic plaques in human coronary arteries","volume":"60","author":"Davies","year":"1988","journal-title":"Br Heart J"},{"issue":"9","key":"10.1016\/j.dld.2019.05.005_bib0110","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.ATV.15.9.1512","article-title":"A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association","volume":"15","author":"Stary","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.dld.2019.05.005_bib0115","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nm0402-403","article-title":"Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis","volume":"8","author":"Sata","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.dld.2019.05.005_bib0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1741-7015-12-47","article-title":"Is atherosclerosis an autoimmune disease?","volume":"12","author":"Matsuura","year":"2014","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.dld.2019.05.005_bib0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.semarthrit.2012.12.002","article-title":"The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review","volume":"43","author":"Schoenfeld","year":"2013","journal-title":"Sem Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.dld.2019.05.005_bib0130","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrcardio.2014.206","article-title":"Cardiorheumatology: cardiac involvement in systemic rheumatic disease","volume":"12","author":"Prasad","year":"2015","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"10.1016\/j.dld.2019.05.005_bib0135","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11883-014-0435-z","article-title":"Inflammation and cardiovascular disease: from pathogenesis to therapeutic target","volume":"16","author":"Golia","year":"2014","journal-title":"Curr Atheroscler Rep"},{"issue":"2","key":"10.1016\/j.dld.2019.05.005_bib0140","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3892\/etm.2016.3966","article-title":"Risk of cardiovascular disease in inflammatory bowel disease","volume":"13","author":"Wu","year":"2017","journal-title":"Exp Ther Med"},{"issue":"1","key":"10.1016\/j.dld.2019.05.005_bib0145","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/sj.clpt.6100229","article-title":"Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn\u2019s disease","volume":"83","author":"Schinzari","year":"2008","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.dld.2019.05.005_bib0150","doi-asserted-by":"crossref","first-page":"379","DOI":"10.14740\/jocmr2122w","article-title":"The increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations","volume":"7","author":"Durante","year":"2015","journal-title":"J Clin Med Res"},{"issue":"2","key":"10.1016\/j.dld.2019.05.005_bib0155","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00296-018-4186-y","article-title":"Common atherosclerosis genetic risk factors and subclinical atherosclerosis in rheumatoid arthritis: the relevance of disease duration","volume":"39","author":"Kisiel","year":"2019","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.dld.2019.05.005_bib0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jacep.2016.05.009","article-title":"Trends in cardiac tamponade among recipients of permanent pacemakers in the United States: from 2008 to. JACC","volume":"3","author":"Moazzami","year":"2012","journal-title":"Clin Electrophysiol"},{"issue":"5","key":"10.1016\/j.dld.2019.05.005_bib0165","first-page":"72","article-title":"Inflammatory bowel disease","volume":"113","author":"Wehkamp","year":"2016","journal-title":"Deutsches Arzteblatt Int"},{"issue":"2 Suppl","key":"10.1016\/j.dld.2019.05.005_bib0170","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1136\/hrt.72.2_Suppl.S3","article-title":"Changing epidemiological features of cardiac failure","volume":"72","author":"Kannel","year":"1994","journal-title":"Br Heart J"},{"issue":"3","key":"10.1016\/j.dld.2019.05.005_bib0175","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1067\/mhj.2002.121264","article-title":"Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure","volume":"143","author":"Baldasseroni","year":"2002","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.dld.2019.05.005_bib0180","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archinte.161.7.996","article-title":"Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study","volume":"161","author":"He","year":"2001","journal-title":"Arc Int Med"},{"issue":"2","key":"10.1016\/j.dld.2019.05.005_bib0185","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.dld.2018.10.004","article-title":"Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine","volume":"51","author":"Giannakopoulos","year":"2019","journal-title":"Dig Liver Dis: Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"issue":"10","key":"10.1016\/j.dld.2019.05.005_bib0190","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/apt.13584","article-title":"A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis","volume":"43","author":"Zachou","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.dld.2019.05.005_bib0195","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/00365521.2015.1095351","article-title":"Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy","volume":"51","author":"Than","year":"2016","journal-title":"Scand J Gastroenterol"},{"issue":"11","key":"10.1016\/j.dld.2019.05.005_bib0200","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.amjmed.2014.06.016","article-title":"Use of sirolimus in the treatment of refractory autoimmune hepatitis","volume":"127","author":"Chatrath","year":"2014","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.dld.2019.05.005_bib0205","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2012.11.010","article-title":"Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis","volume":"58","author":"Weiler-Normann","year":"2013","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2019.05.005_bib0210","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cgh.2015.09.037","article-title":"Efficacy of 6-mercaptopurine as second-line treatment for patients with autoimmune hepatitis and azathioprine intolerance","volume":"14","author":"Hubener","year":"2016","journal-title":"Clin Gastroenterol Hepatol: Official Clin Pract J Am Gastroenterol Assoc"},{"issue":"2","key":"10.1016\/j.dld.2019.05.005_bib0215","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3892\/etm.2016.3966","article-title":"Risk of cardiovascular disease in inflammatory bowel disease","volume":"13","author":"Wu","year":"2017","journal-title":"Exp Ther Med"},{"issue":"1","key":"10.1016\/j.dld.2019.05.005_bib0220","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nrgastro.2014.202","article-title":"Epidemiology, risk factors and management of cardiovascular diseases in IBD","volume":"12","author":"Singh","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1 Suppl","key":"10.1016\/j.dld.2019.05.005_bib0225","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2015.03.005","article-title":"Autoimmune hepatitis-Update 2015","volume":"62","author":"Manns","year":"2015","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.dld.2019.05.005_bib0230","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0168-8278(91)90940-D","article-title":"Reduced cardiovascular responsiveness to exercise-induced sympathoadrenergic stimulation in patients with cirrhosis","volume":"12","author":"Bernardi","year":"1991","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.dld.2019.05.005_bib0235","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/gut.49.2.268","article-title":"The cardiac response to exercise in cirrhosis","volume":"49","author":"Wong","year":"2001","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.dld.2019.05.005_bib0240","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1111\/j.1572-0241.2000.03252.x","article-title":"Modification of cardiac function in cirrhotic patients with and without ascites","volume":"95","author":"Valeriano","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.dld.2019.05.005_bib0245","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/00365529609004879","article-title":"Left ventricular diastolic function in liver cirrhosis","volume":"31","author":"Finucci","year":"1996","journal-title":"Scand J Gastroenterol"},{"issue":"41","key":"10.1016\/j.dld.2019.05.005_bib0250","doi-asserted-by":"crossref","first-page":"11502","DOI":"10.3748\/wjg.v21.i41.11502","article-title":"Cirrhotic cardiomyopathy","volume":"21","author":"Ruiz-del-\u00c1rbol","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.dld.2019.05.005_bib0255","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/hep.26509","article-title":"Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine","volume":"58","author":"Ru\u00edz-del-\u00c1rbol","year":"2013","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"6","key":"10.1016\/j.dld.2019.05.005_bib0260","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2019","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.dld.2019.05.005_bib0265","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1161\/01.RES.0000150734.79804.92","article-title":"Cytokine-induced modulation of cardiac function","volume":"95","author":"Prabhu","year":"2004","journal-title":"Circ Res"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865819305833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865819305833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:11:13Z","timestamp":1761624673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865819305833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1590865819305833"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2019.05.005","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Autoimmune Hepatitis and Cardiovascular Disease","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2019.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}